BERLIN: In a significant move, Germany has introduced a draft bill to legalize cannabis for personal use, allowing adults to grow and consume restricted quantities of the substance. The proposal, approved by Chancellor Olaf Scholz’s Cabinet, marks a turning point in the country’s approach to drug policy, aiming to address the challenges posed by the black market and drug-related crime.
Health Minister Karl Lauterbach presented the draft legislation at a news conference in Berlin, highlighting its potential to combat the existing issues with cannabis consumption and its illicit trade. Lauterbach emphasized that the controlled legalization of cannabis represents a more effective strategy, as previous measures failed to curtail consumption and inadvertently led to a rise in drug-related criminal activities.
Lauterbach expressed concern over the current black market, which often provides cannabis products with toxic dosages or harmful additives. The new legislation seeks to counter these risks by offering a legal avenue for obtaining cannabis, thereby promoting public health and safety.
Bill to Legalize Cannabis in Germany
Under the proposed bill, individuals aged 18 and above will be permitted to possess up to 25 grams of cannabis. Moreover, adults will have the option to self-cultivate up to three cannabis plants for personal consumption. Notably, non-profit associations with a maximum of 500 members will be allowed to cultivate and distribute cannabis to their members, with a monthly limit of 50 grams per member.
The bill is designed to address key concerns while still maintaining safeguards, particularly for teenagers, for whom cannabis use will remain illegal. By providing legal alternatives and controlled access, the German government aims to reduce the prevalence of toxic substances and minimize the risk of harm associated with illicit cannabis consumption.
To become law, the draft legislation requires parliamentary approval and is slated for discussion at the Bundestag following the summer recess. Germany’s move towards limited cannabis legalization reflects a growing global trend towards reevaluating drug policies, with an emphasis on harm reduction and regulatory control.
